Pathogenetic therapy of multiple sclerosis
Veĭn, A.M.; Smirnov, I.K.
Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(2): 181-185
1983
ISSN/ISBN: 0044-4588 PMID: 6858476 Document Number: 220798
Document emailed within 1 workday
Related Documents
Golovkin, V.I.; Mikhaĭlenko, A.A.; Rakov, A.L. 1991: Pathogenetic role of prolactinemia in multiple sclerosis Sovetskaia Meditsina 10: 15-17Gusev, E.I.; Boĭko, A.N. 2001: Some clinical and medicosocial aspects of new methods of multiple sclerosis pathogenetic treatment Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 101(12): 7-12
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Kesselring, J. 1984: Therapy of multiple sclerosis Schweizerische Medizinische Wochenschrift 114(35): 1186-1190
Simó, M. 2009: Therapy of multiple sclerosis Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(1): 23-26
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Salvatores, U.; Majeron, M.; Mascetti, A. 1972: Cyclophosphamide in the therapy of multiple sclerosis Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali 96(1): 163-184
Vass, K.; Schmied, M. 1996: Current therapy of multiple sclerosis Wiener Medizinische Wochenschrift 146(19-20): 514-519
Nouza, K.; Krejcová, H. 1997: Pathogenesis and therapy of multiple sclerosis Bratislavske Lekarske Listy 98(4): 199-203
Pallotta, R. 1982: Hyperbaric therapy of multiple sclerosis Minerva Medica 73(42): 2947-2954
Csépány, T.ün.; Bereczki, D.án. 2004: Immunomodulatory therapy in multiple sclerosis Ideggyogyaszati Szemle 57(11-12): 401-416
Le Page, E.; Edan, G. 2006: Drug therapy in multiple sclerosis La Revue du Praticien 56(12): 1336-1346
Reichel, D.; Kölmel, H.W. 1995: Multiple sclerosis--current status of therapy Zeitschrift für Arztliche Fortbildung 89(2): 151-158
Hohlfeld, R. 1999: Immunological basis for the therapy of multiple sclerosis Acta Neurologica Belgica 99(1): 40-43
Rodgers, D.; Khoo, K.; MacEachen, M.; Oven, M.; Beatty, W.W. 1996: Cognitive therapy for multiple sclerosis: a preliminary study Alternative Therapies in Health and Medicine 2(5): 70-74
Benesova, Y.; Stourac, P.; Beranek, M.; Kadanka, Z. 2005: Mitoxantrone therapy in rapidly worsening multiple sclerosis Bratislavske Lekarske Listy 106(3): 141-143
Schmidt, S.; Hohlfeld, R. 1995: Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins? Der Nervenarzt 66(4): 304-307